Access and affordability constraints limit the population that can benefit from current therapies
Improvement in fibrosis was also assessed, showing a dose-dependent trend, with 34% of patients achieving at least a 1-stage improvement in fibrosis without MASH progression in the 6 mg group (vs
While not approved to treat these conditions, in a clinical trial, people who dieted, exercised and took Zepbound for the treatment of obesity or overweight with weight-related medical problems observed changes in cholesterol and reductions in blood pressure and waist size
Some patients may seek a more permanent solution with bariatric surgery
Research on a human model indicated that Scabra extracts (100 mg/kg) reduced glucose levels in db/db mice during the oral glucose tolerance test (OGTT) while plasma GLP-1 and insulin levels significantly rose 10 min post-administration [33]
Safety profile comparison More effective does not always mean more side effects